In 2012, the US Preventative Services Task Force (USPSTF) stunned the medical and lay community with its recommendation against routine prostate-specific antigen tests or, PSA screenings, for prostate cancer. This screening can detect high levels of PSA that may indicate the presence of prostate cancer. The Task Force gave PSA screening a grade of “D” primarily based on the results of the Prostate, Lung, Colorectal, and Ovary (PCLO) trial, reported in 2009, which showed no difference in prostate cancer incidence or mortality between the screening and control groups after 7 years. Since this seminal declaration, screening has decreased from 33% to 18.7% in men aged 55-69 years, the age range generally thought to be most critical in identifying and treating the second-leading cause of cancer death in men.
A recent article in MD News chronicles the latest move by NWH to ensure that colorectal surgery and other laparoscopic procedures performed at Northern Westchester Hospital is more precise than even more. Using the da Vinci Surgical System Robot is paramount for NWH surgeons. This pioneering instrument is proving to be an appreciated top choice for the department, and perhaps a game changer for doctors at NWH in Westchester County.
Robot-assisted Surgery Got its Start on the Battlefield
by Dr. Warren Bromberg
The original destination for guided robotic surgery was the battlefield: The hope was that expert surgeons could operate on injured soldiers remotely. While these plans have yet to pan out, robotic technology has been adapted for civilian use.
Northern Westchester Hospital now has two such devices, the da Vinci® Surgical System.